Latest News

Today’s top news highlights: Primary care practices struggle, Americans split on COVID-19 vaccine

Publish date: May 27, 2020

 

Biologic approved for atopic dermatitis

The Food and Drug Administration approved dupilumab for children aged 6-11 years with moderate to severe atopic dermatitis. This is the first biologic approved for atopic dermatitis in this age group. The new indication is for children whose disease is not adequately controlled with topical prescription therapies. READ MORE.

For more on COVID-19, visit our Resource Center. All of our latest news is available on MDedge.com.

Pages

Recommended Reading

Social isolation tied to higher risk of cardiovascular events, death
MDedge Internal Medicine
Family physicians have lowest incentive bonuses, survey finds
MDedge Internal Medicine
Primary care practices struggle to survive despite visit rebound
MDedge Internal Medicine
COVID-19: Psychiatrists assess geriatric harm from social distancing
MDedge Internal Medicine
Severe disease not uncommon in children hospitalized with COVID-19
MDedge Internal Medicine
Can you catch COVID-19 through your eyes?
MDedge Internal Medicine
Seek safe strategies to diagnose gestational diabetes during pandemic
MDedge Internal Medicine
Domestic violence amid COVID-19: Helping your patients from afar
MDedge Internal Medicine
Half of Americans would get COVID-19 vaccine, poll shows
MDedge Internal Medicine
COVID-19 complicates prescribing for children with inflammatory skin disease
MDedge Internal Medicine